FDA
-
-
-
-
-
-
-
TriSalus to present drug delivery data at 2026 radiology meeting
-
-
-
-
-
-
-
TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call
-
-
-
-
-
-
-
TriSalus reports Q4 revenue of $13.2 million, up 60% year-over-year
-
-
-
-
-
-
-
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
-
-
-
-
-
-
-
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav®
-
-
-
-
-
-
-
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
-
322,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

